Literature DB >> 7065690

Corticosteroid-induced cataracts in idiopathic nephrotic syndrome.

J T Brocklebank, R B Harcourt, S R Meadow.   

Abstract

Th incidence and severity of posterior subcapsular cataracts were studied in 58 children with steroid-sensitive nephrotic syndrome. Eight (14%) children had cataracts. Visual acuity was normal in all but one child. There was no relationship between total dose or mean daily dose of prednisolone (corrected for body surface area) and cataract formation. Alternate-day treatment with prednisolone for an average of half the total treatment time did not prevent cataracts. These studies show there is little risk of causing permanent visual handicap in children with steroid sensitive nephrotic syndrome, provided prednisolone treatment is carefully controlled.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7065690      PMCID: PMC2863278     

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  15 in total

1.  Examination of lenses of steroid-treated rats.

Authors:  L VON SALLMANN; L L CARAVAGGIO; E M COLLINS; K WEAVER
Journal:  Am J Ophthalmol       Date:  1960-12       Impact factor: 5.258

2.  Examination for posterior subcapsular cataracts. A preliminary report of results in forty-five rheumatoid patients treated with corticosteroids.

Authors:  D M GORDON; W H KAMMERER; R H FREYBERG
Journal:  JAMA       Date:  1961-01-14       Impact factor: 56.272

3.  Cataracts in patients with rheumatic diseases treated with corticosteroids. Further observations.

Authors:  R B OGLESBY; R L BLACK; L VON SALLMANN; J J BUNIM
Journal:  Arch Ophthalmol       Date:  1961-11

4.  The relationship of steroid therapy and cataracts in patients with rheumatoid arthritis.

Authors:  S B PFAHL; T A MAKLEY; N O ROTHERMICH; F W McCOY
Journal:  Am J Ophthalmol       Date:  1961-11       Impact factor: 5.258

5.  Posterior subcapsular cataract in nephrotic children receiving steroid therapy.

Authors:  Y Kobayashi; K Akaishi; T Nishio; Y Kobayashi; Y Kimura
Journal:  Am J Dis Child       Date:  1974-11

6.  Posterior subcapsular cataracts. Related to long-term corticosteroid treatment in children.

Authors:  M Bihari; B J Grossman
Journal:  Am J Dis Child       Date:  1968-12

7.  Posterior subcapsular cataracts and glaucoma associated with long-term oral corticosteroid therapy. In patients with rheumatoid arthritis and related conditions.

Authors:  J Williamson; R W Paterson; D D McGavin; M K Jasani; J A Boyle; W M Doig
Journal:  Br J Ophthalmol       Date:  1969-06       Impact factor: 4.638

8.  Posterior subcapsular cataracts: posttransplantation in children.

Authors:  R N Fine; G Offner; W A Wilson; M R Mickey; A F Pennisi; M H Malekzadeh
Journal:  Ann Surg       Date:  1975-11       Impact factor: 12.969

9.  Dose dependent pharmacokinetics of prednisolone.

Authors:  M E Pickup; J R Lowe; P A Leatham; V M Rhind; V Wright; W W Downie
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953

10.  Steroid cataract.

Authors:  C Fürst; W K Smiley; B M Ansell
Journal:  Ann Rheum Dis       Date:  1966-07       Impact factor: 19.103

View more
  9 in total

1.  Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: general therapy.

Authors:  Yoshitsugu Kaku; Yasufumi Ohtsuka; Yasuhiro Komatsu; Toshiyuki Ohta; Takuhito Nagai; Hiroshi Kaito; Shuji Kondo; Yohei Ikezumi; Seiji Tanaka; Shinsuke Matsumoto; Mayumi Sako; Kazushi Tsuruga; Koichi Nakanishi; Koichi Kamei; Hiroshi Saito; Shuichiro Fujinaga; Yuko Hamasaki; Hiroko Chikamoto; Kenji Ishikura; Kazumoto Iijima
Journal:  Clin Exp Nephrol       Date:  2015-02       Impact factor: 2.801

2.  Loss of αB-crystallin function in zebrafish reveals critical roles in the development of the lens and stress resistance of the heart.

Authors:  Sanjay Mishra; Shu-Yu Wu; Alexandra W Fuller; Zhen Wang; Kristie L Rose; Kevin L Schey; Hassane S Mchaourab
Journal:  J Biol Chem       Date:  2017-11-21       Impact factor: 5.157

Review 3.  Consensus statement on management and audit potential for steroid responsive nephrotic syndrome. Report of a Workshop by the British Association for Paediatric Nephrology and Research Unit, Royal College of Physicians.

Authors: 
Journal:  Arch Dis Child       Date:  1994-02       Impact factor: 3.791

4.  Long-term results of children diagnosed with idiopathic nephrotic syndrome; single center experience.

Authors:  Duygu Övünç Hacıhamdioğlu; Süleyman Kalman; Faysal Gök
Journal:  Turk Pediatri Ars       Date:  2015-03-01

5.  The long-term outcome of childhood nephrotic syndrome in Germany: a cross-sectional study.

Authors:  Malik Aydin; Ingo Franke; Lisa Kurylowicz; Rainer Ganschow; Michael Lentze; Mark Born; Rebekka Hagemann
Journal:  Clin Exp Nephrol       Date:  2019-02-05       Impact factor: 2.801

6.  Association between Immunoglobulin M and Steroid Resistance in Children with Nephrotic Syndrome: A Retrospective Multicenter Study in Japan.

Authors:  Tomohiro Udagawa; Yusuke Matsuyama; Mika Okutsu; Yaeko Motoyoshi; Mari Okada; Norimasa Tada; Eriko Kikuchi; Masuhiro Shimoda; Toru Kanamori; Tae Omori; Masaki Takahashi; Kohsuke Imai; Akifumi Endo; Takeo Fujiwara; Tomohiro Morio
Journal:  Kidney360       Date:  2021-01-19

7.  Ocular complications in children with nephrotic syndrome on long term oral steroids.

Authors:  S Gaur; M Joseph; S Nityanandam; S Subramanian; A S Koshy; A Vasudevan; K D Phadke; A Iyengar
Journal:  Indian J Pediatr       Date:  2014-02-21       Impact factor: 1.967

8.  Prevalence and predictors of ocular complications among children undergoing nephrotic syndrome treatment in a resource-limited setting.

Authors:  Faith Nakubulwa; Rebecca Claire Lusobya; Anthony Batte; Bashir Ssuna; Damalie Nakanjako; Lydia Nakiyingi; Caroline Nalukenge; Francis Onen Sebabi; Ben Mulinde; Juliet Otiti-Sengeri
Journal:  BMC Ophthalmol       Date:  2021-01-22       Impact factor: 2.209

9.  Effects of dexamethasone on human lens epithelial cells in culture.

Authors:  A Petersen; T Carlsson; J-O Karlsson; S Jonhede; M Zetterberg
Journal:  Mol Vis       Date:  2008-07-21       Impact factor: 2.367

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.